Mylène Jansen

348 Chapter 16 Supplementary Figure 2 : Scatter plots showing the association between the change in synovial fluid analyte for each individual over the distraction period with the change in clinical outcome KOOS 4 over 6 months, for each of the 10 analytes (regression statistics for these data are shown in middle panel of Figure 4A and Supplementary Table 2). FGF-2: basic fibroblast growth factor; IL-6: interleukin 6; IL-8: interleukin 8; KOOS 4 : Knee injury and osteoarthritis outcome score-4; LTBP2: latent-transforming growth factor beta-binding protein 2; MCP-1: monocyte chemoattractant protein 1; MMP3, matrix metalloproteinase-3; TGF β -1: transforming growth factor beta 1; TIMP-1: tissue inhibitor of metalloproteinases 1; TSG-6: TNF stimulated protein-6.